Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-operative atrial fibrillation after surgical aortic valve replacement and the influence of atorvastatin
2024-511601-34-00Phase 4Authorised
- Sponsor
- University Hospital Odense
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Atrial fibrillation (AFib) comparing Atorvastatin treatment with Placebo/control (2 arms). Primary endpoints: Number of participants with post-operative atrial fibrillation in hospital, Number of participants with post-operative atrial fibrillation within 30 days and 1 more. Planned start Mar 2022; status: authorised.
02
Drugs
atorvastatin
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2024-511601-34-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511601-34-00.